Skip to main content
Top
Published in: Journal of Nephrology 2/2021

Open Access 01-04-2021 | Acute Kidney Injury | Original Article

Acute kidney injury and mortality risk in older adults with COVID-19

Authors: Hong Xu, Sara Garcia-Ptacek, Martin Annetorp, Annette Bruchfeld, Tommy Cederholm, Peter Johnson, Miia Kivipelto, Carina Metzner, Dorota Religa, Maria Eriksdotter

Published in: Journal of Nephrology | Issue 2/2021

Login to get access

Abstract

Background

Research regarding COVID-19 and acute kidney injury (AKI) in older adults is scarce. We evaluated risk factors and outcomes of AKI in hospitalized older adults with and without COVID-19.

Methods

Observational study of patients admitted to two geriatric clinics in Stockholm from March 1st to June 15th, 2020. The difference in incidence, risk factors and adverse outcomes for AKI between patients with or without COVID-19 were examined. Odds ratios (OR) for the risk of AKI and in-hospital death were obtained from logistic regression.

Results

Three hundred-sixteen older patients were hospitalized for COVID-19 and 876 patients for non-COVID-19 diagnoses. AKI occurred in 92 (29%) patients with COVID-19 vs. 159 (18%) without COVID-19. The odds for developing AKI were higher in patients with COVID-19 (adjusted OR, 1.70; 95% confidence interval [CI] 1.04–2.76), low baseline kidney function as depicted by estimated glomerular filtration rate (eGFR) [4.19 (2.48–7.05), for eGFR 30 to  < 60 mL/min, and 20.3 (9.95–41.3) for eGFR < 30 mL/min], and higher C reactive protein (CRP) (OR 1.81 (1.11–2.95) in patients with initial CRP > 10 mg/L). Compared to patients without COVID-19 and without AKI, the risk of in-hospital death was highest in patients with COVID-19 and AKI [OR 80.3, 95% CI (27.3–235.6)], followed by COVID-19 without AKI [16.3 (6.28–42.4)], and by patients without COVID-19 and with AKI [10.2 (3.66–28.2)].

Conclusions

Geriatric patients hospitalized with COVID-19 had a higher incidence of AKI compared to patients hospitalized for other diagnoses. COVID-19 and reduced baseline kidney function were risk factors for developing AKI. AKI and COVID-19 were associated with in-hospital death.
Appendix
Available only for authorised users
Literature
7.
go back to reference Angel-Korman A, Brosh T, Glick K, Leiba A (2020) COVID-19, THE KIDNEY AND HYPERTENSION. Harefuah 159:231–234PubMed Angel-Korman A, Brosh T, Glick K, Leiba A (2020) COVID-19, THE KIDNEY AND HYPERTENSION. Harefuah 159:231–234PubMed
23.
go back to reference Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRefPubMed Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRefPubMed
28.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure— definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (London, England) 8:R204-212. https://doi.org/10.1186/cc2872CrossRef Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure— definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (London, England) 8:R204-212. https://​doi.​org/​10.​1186/​cc2872CrossRef
Metadata
Title
Acute kidney injury and mortality risk in older adults with COVID-19
Authors
Hong Xu
Sara Garcia-Ptacek
Martin Annetorp
Annette Bruchfeld
Tommy Cederholm
Peter Johnson
Miia Kivipelto
Carina Metzner
Dorota Religa
Maria Eriksdotter
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2021
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-021-01022-0

Other articles of this Issue 2/2021

Journal of Nephrology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.